(Q36645461)

English

Systematic review of clinical outcomes in chronic obstructive pulmonary disease: beta-agonist use compared with anticholinergics and inhaled corticosteroids

scientific article published on October 2006

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

1 reference

Europe PubMed Central

Systematic review of clinical outcomes in chronic obstructive pulmonary disease: beta-agonist use compared with anticholinergics and inhaled corticosteroids (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

chronic obstructive pulmonary disease

1 reference

based on heuristic

inferred from title

systematic review

1 reference

based on heuristic

inferred from title

Shelley R. Salpeter

1

object named as

Shelley R Salpeter

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

author name string

Nicholas S Buckley

2

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

publication date

1 October 2006

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Clinical Reviews in Allergy & Immunology

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

31

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

2-3

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

219-230

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

One-year cost-effectiveness of tiotropium versus ipratropium to treat chronic obstructive pulmonary disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of anticholinergics in chronic obstructive pulmonary disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased bronchial hyperresponsiveness after inhaling salbutamol during 1 year is not caused by subsensitization to salbutamol

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: a comparison between budesonide and terbutaline.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined corticosteroid and longacting beta-agonist in one inhaler for chronic obstructive pulmonary disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhaled corticosteroids reduce the progression of airflow limitation in chronic obstructive pulmonary disease: a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The spirometric efficacy of once-daily dosing with tiotropium in stable COPD: a 13-week multicenter trial. The US Tiotropium Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Scope and impact of financial conflicts of interest in biomedical research: a systematic review

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Guidelines versus clinical practice in the treatment of chronic obstructive pulmonary disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. International COPD Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An empirical comparison of the St George's Respiratory Questionnaire (SGRQ) and the Chronic Respiratory Disease Questionnaire (CRQ) in a clinical trial setting

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk of myocardial ischaemia and beta-adrenoceptor agonists

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic obstructive pulmonary disease. National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiovascular safety of beta(2)-adrenoceptor agonist use in patients with obstructive airway disease: a systematic review

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An evaluation of salmeterol in the treatment of chronic obstructive pulmonary disease (COPD)

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nebulized bronchodilators for outpatient management of stable chronic obstructive pulmonary disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suboptimal medical therapy in COPD: exploring the causes and consequences

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Routine nebulized ipratropium and albuterol together are better than either alone in COPD. The COMBIVENT Inhalation Solution Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tolerance to bronchodilating effects of salmeterol in COPD

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease--2003.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patterns of increasing beta-agonist use and the risk of fatal or near-fatal asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind placebo-controlled study of the effect of inhaled beclomethasone dipropionate for 2 years in patients with nonasthmatic chronic obstructive pulmonary disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Formoterol in patients with chronic obstructive pulmonary disease: a randomized, controlled, 3-month trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The reality of drug use in COPD: the European perspective

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the efficacy, tolerability, and safety of formoterol dry powder and oral, slow-release theophylline in the treatment of COPD.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ipratropium bromide hydrofluoroalkane inhalation aerosol is safe and effective in patients with COPD.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of long-term treatment with corticosteroids in COPD

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regular versus as-needed short-acting inhaled beta-agonist therapy for chronic obstructive pulmonary disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Letter: Deaths in asthma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Conflict of interest in the debate over calcium-channel antagonists

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the anticholinergic bronchodilator ipratropium bromide with metaproterenol in chronic obstructive pulmonary disease. A 90-day multi-center study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiovascular Effects of AH.3365 (Salbutamol)

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison between long-term treatment of chronic bronchitic airway obstruction with ipratropium bromide and metaproterenol

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regular inhaled beta-agonist treatment in bronchial asthma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of a long-acting inhaled beta2-adrenergic agonist, salmeterol xinafoate, in patients with chronic obstructive pulmonary disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Corticosteroid therapy for patients with acute exacerbations of chronic obstructive pulmonary disease: a systematic review.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Letter: Death in asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recent developments in inhaled therapy in stable chronic obstructive pulmonary disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhaled short-acting beta2-agonists versus ipratropium for acute exacerbations of chronic obstructive pulmonary disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of formoterol and ipratropium bromide in COPD: a 3-month placebo-controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

COPD, a multicomponent disease: implications for management

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of inhaled corticosteroids on sputum cell counts in stable chronic obstructive pulmonary disease: a systematic review and a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long acting beta2 agonists for stable chronic obstructive pulmonary disease with poor reversibility: a systematic review of randomised controlled trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Statistical aspects of the analysis of data from retrospective studies of disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tiotropium for stable chronic obstructive pulmonary disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The beta-adrenoceptor

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The beta-agonist controversy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Short-acting beta 2 agonists for stable chronic obstructive pulmonary disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Meta-analysis: respiratory tolerance to regular beta2-agonist use in patients with asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The addition of salmeterol 50 microg bid to anticholinergic treatment in patients with COPD: a randomized, placebo controlled trial. Chronic obstructive pulmonary disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long term effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacoeconomic evaluation of a combination of ipratropium plus albuterol compared with ipratropium alone and albuterol alone in COPD

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised controlled trial of inhaled corticosteroids in patients with chronic obstructive pulmonary disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term treatment of chronic obstructive pulmonary disease with salmeterol and the additive effect of ipratropium

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risks versus benefits of inhaled beta 2-agonists in the management of asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review of randomized placebo-controlled trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Meta-analysis: effect of long-acting beta-agonists on severe asthma exacerbations and asthma-related deaths

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Controversies involving inhaled beta-agonists and inhaled corticosteroids in the treatment of asthma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Meta-analysis: anticholinergics, but not beta-agonists, reduce severe exacerbations and respiratory mortality in COPD.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Asthma control during and after cessation of regular beta 2-agonist treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: a randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17085795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1385/CRIAI:31:2:219

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36645461&oldid=2199134461"